A detailed history of Teza Capital Management LLC transactions in Amgen Inc stock. As of the latest transaction made, Teza Capital Management LLC holds 5,368 shares of AMGN stock, worth $1.49 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares
5,368
Holding current value
$1.49 Million
% of portfolio
0.19%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$309.38 - $337.38 $1.66 Million - $1.81 Million
5,368 New
5,368 $1.73 Million
Q3 2023

Feb 22, 2024

BUY
$218.65 - $271.46 $390,727 - $485,099
1,787 Added 82.54%
3,952 $1.06 Million
Q3 2023

Nov 14, 2023

BUY
$218.65 - $271.46 $954,625 - $1.19 Million
4,366 Added 448.25%
5,340 $1.44 Million
Q2 2023

Aug 14, 2023

SELL
$214.27 - $253.37 $341,117 - $403,365
-1,592 Reduced 62.04%
974 $216,000
Q1 2023

Feb 22, 2024

BUY
$225.79 - $275.2 $488,835 - $595,808
2,165 New
2,165 $523,000
Q1 2023

May 15, 2023

BUY
$225.79 - $275.2 $579,377 - $706,163
2,566 New
2,566 $620,000
Q2 2022

Aug 15, 2022

BUY
$230.71 - $256.74 $288,156 - $320,668
1,249 Added 58.34%
3,390 $825,000
Q1 2022

May 16, 2022

BUY
$219.27 - $242.57 $232,426 - $257,124
1,060 Added 98.06%
2,141 $518,000
Q4 2021

Feb 14, 2022

BUY
$198.88 - $227.6 $214,989 - $246,035
1,081 New
1,081 $243,000
Q1 2021

May 13, 2021

SELL
$221.91 - $258.6 $1.46 Million - $1.7 Million
-6,578 Closed
0 $0
Q4 2020

Feb 12, 2021

BUY
$216.38 - $257.67 $1.42 Million - $1.69 Million
6,578 New
6,578 $1.51 Million
Q3 2018

Nov 14, 2018

SELL
$185.29 - $208.89 $1.01 Million - $1.14 Million
-5,446 Closed
0 $0
Q2 2018

Aug 14, 2018

SELL
$166.05 - $186.51 $66,420 - $74,604
-400 Reduced 6.84%
5,446 $1.01 Million
Q1 2018

May 11, 2018

BUY
$169.43 - $198.0 $77,090 - $90,090
455 Added 8.44%
5,846 $997,000
Q4 2017

Feb 14, 2018

BUY
$168.79 - $188.59 $909,946 - $1.02 Million
5,391
5,391 $937,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $149B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Teza Capital Management LLC Portfolio

Follow Teza Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Teza Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Teza Capital Management LLC with notifications on news.